Loading

Biotech
Companies

As the complexity of drug discovery and development steadily increases, so do the costs. With average expenditures for prescription drug R&D ranging between $2.5 – $3.0 billion, emerging biotech companies are facing a number of challenges.
From clinical development strategy to commercial success, Fervor provides flexible, tailored, integrated clinical and commercial solutions designed to help smaller biotech companies move forward in their effort to get treatments to patients – from defining the plan for their asset, to trial design and implementation, through launch and commercialization – all while delivering compelling results to investors, stakeholders and regulatory authorities with confidence.

Advance your asset’s Value Across Milestones

On the surface, your milestones may look the same as large Pharma’s. But we know that you face very different questions along your journey. The answers to those questions can impact not only your product’s probability of success, but that of your overall company.
let's talk

about your next project .

Copyright © – 2021 Fervor Health Services. All rights reserved.